Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Annals of Gastroenterology|January 8, 2021
Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogsSpyros Siakavellas, John Goulis, Spilios Manolakopoulos, et al.
Cancers|July 27, 2024
Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular CarcinomaStavros P Papadakos, Elena Chatzikalil, Georgios Vakadaris, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2016
Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experienceNikolaos Papadopoulos, Melanie Deutsch, Spilios Manolakopoulos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2010
Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis CSpilios Manolakopoulos, Melanie J Deutsch, Olga Anagnostou, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosisAlec Avgerinos, Anastasios Armonis, Gerasimos Stefanidis, et al.
Antiviral Therapy|July 26, 2018
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis BGeorge V Papatheodoridis, Eirini I Rigopoulou, Margarita Papatheodoridi, et al.
Annals of Gastroenterology|August 29, 2017
Prioritization for interferon-free regimens and potential drug interactions of current direct-acting anti-hepatitis C agents in routine clinical practiceΜargarita Papatheodoridi, George N Dalekos, John Goulis, et al.
Hepato-Gastroenterology|May 30, 2008
Fibrous ring formation in cirrhotics treated with band ligationChristos Triantos, Spilios Manolakopoulos, Jiannis Anastasiou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2020
Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analoguesSpilios Manolakopoulos, Hariklia Kranidioti, Anastasia Kourikou, et al.
Hepatology (Baltimore, Md.)|October 17, 2008
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?George V Papatheodoridis, Emanuel K Manesis, Spilios Manolakopoulos, et al.
Pageof 11